Tags

Hau Giang Pharmaceutical Joint Stock Company (DHG)

VN healthcare market, a big draw for investors, foreign and local

VN healthcare market, a big draw for investors, foreign and local

Last year, VinaCapital’s flagship fund, Vietnam Opportunity Fund (VOF), invested US$25 million in a private hospital operator, Tam Tri Medical Joint Stock Company.
Pharmaceutical stocks benefit from disease spread

Pharmaceutical stocks benefit from disease spread

Pharmaceutical stocks are experiencing an upsurge as fears of coronavirus have boosted demand for healthcare products and services, lifting demand for shares.
DHG sees profits rise

DHG sees profits rise

The Hau Giang Pharmaceutical Joint Stock Company (DHG) is expected to attain post-tax profit of VND705 billion in 2018, up 10 per cent year-on-year, Bao Viet Securities Company (BVSC) forecasts.
Pharmaceutical companys profit up 6 per cent

Pharmaceutical company’s profit up 6 per cent

Hau Giang Pharmaceutical Joint Stock Company, one of the leading companies in the pharmaceutical cosmetics industry, recorded profit of VND190 billion (US$4.3 million) in the second quarter of this year, up 6 per cent on-year.
DHG Pharma lifts foreign ownership limit to 100 per cent

DHG Pharma lifts foreign ownership limit to 100 per cent

Hau Giang Pharmaceutical Joint Stock Company, DHG Pharma, has completed the procedures to lift the foreign ownership cap from its current rate of 49 per cent to 100 per cent, effectively abolishing the cap altogether.
VCSC downgrade local pharmacy firm

VCSC downgrade local pharmacy firm

The Viet Capital Securities Joint Stock Company (VCSC) has forecast a bleak outlook on sluggish sales and rising input costs for Hau Giang Pharmaceutical Joint Stock Company (DHG).
Hau Giang Pharmaceutical appoints new chairman

Hau Giang Pharmaceutical appoints new chairman

Hau Giang Pharmaceutical Joint Stock Company (DHG)’s Board of Directors (BOD) has appointed Nguyen Chi Thanh as the new chairman of the company, starting October 26.
Hau Giang Pharmacy to remove foreign-ownership limitations

Hau Giang Pharmacy to remove foreign-ownership limitations

Hau Giang Pharmaceutical Joint Stock Company (DHG) plans to raise its foreign ownership ratio cap from 49 per cent to 100 per cent, DHG leaders on Thursday released in minutes of the company’s extraordinary shareholders meeting for 2017.
Taisho buys 24.5% of VNs DHG drug manufacturer

Taisho buys 24.5% of VN's DHG drug manufacturer

Japanese drug manufacturer Taisho Group has acquired more than 21.3 million shares or a 24.4 per cent stake in Hau Giang Pharmaceutical Joint Stock Company (DHG), the group announced yesterday.